is glp 1 an incretin Mechanism of action of GLP-1 agonists – My Endo Consult Figure 4 from Two incretin

Preclinical studies have shown KPV significantly reduces the severity of intestinal inflammation, decreases pro-inflammatory cytokine activity, and supports intestinal barrier repair

Impact on cancer, mortality risks During mean follow-up of 3.9 years, investigators identified 2,501 new obesity-related cancers in the GLP-1 group and 2,671 in the DPP-4 group

Among different chemotherapy regimens, only those patients treated with taxane (including steroid premedication) in combination with pembrolizumab show improved OS

Understanding the mechanisms underpinning these effects is also important, as it may provide additional information on the cross-talk between cannabinoids and physiological pathways that regulate appetite and metabolism